Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Overcoming the legal and regulatory barriers to drug repurposing

Nature Reviews Drug Discovery volume 18, pages 1–2 (2019)Cite this article

Subjects

Abstract

Drug repurposing has been proposed as a strategy to develop new therapies that has fewer risks, lower costs and shorter timelines than developing completely new drugs. However, the potential of this strategy has not been as widely realized as hoped, in part owing to legal and regulatory barriers. Here, we highlight these barriers and consider how they could be overcome.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673–683 (2004).

    Article  CAS  Google Scholar 

  2. Grabowski, H. Follow-on biologics: data exclusivity and the balance between innovation and competition. Nat. Rev. Drug Discov. 7, 479–488 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Liverpool, Liverpool, UK

    Alasdair Breckenridge

  2. University College London, London, UK

    Robin Jacob

Authors
  1. Alasdair Breckenridge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robin Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alasdair Breckenridge.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Breckenridge, A., Jacob, R. Overcoming the legal and regulatory barriers to drug repurposing. Nat Rev Drug Discov 18, 1–2 (2019). https://doi.org/10.1038/nrd.2018.92

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2018.92

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research